This inventor holds 3 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1994-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-1997
Title: The Innovative Contributions of Matthias Brautigam
Introduction
Matthias Brautigam, a prominent inventor based in Berlin, Germany, has made significant strides in the field of chemistry and pharmaceuticals. With a total of three patents to his name, his innovative work focuses primarily on vitamin D derivatives, which showcase his commitment to advancing scientific research and practical applications in medicine.
Latest Patents
Brautigam's most recent patents include breakthroughs in the area of 24-homo vitamin D derivatives. His first patent details a process for their production, highlighting compounds where R¹ can represent various functional groups, including hydrogen atoms and hydroxy or alkanoyloxy groups. These compounds demonstrate profound potential in inhibiting proliferation and promoting cell differentiation, marking a significant advancement in the therapeutic application of vitamin D.
The second patent delves into side-chain homologous vitamin D derivatives, again presenting compounds characterized by specific formulas, which include a range of aliphatic and oxy alkylene radicals. This invention not only expands the existing knowledge in vitamin D chemistry but also opens doors for future medical applications targeting various health conditions.
Career Highlights
Matthias Brautigam is affiliated with Schering Aktiengesellschaft, a leading biopharmaceutical company that fosters innovation in healthcare. His work involves extensive research that not only contributes to patentable inventions but also positions his company at the forefront of scientific advancements in the realm of vitamin D derivatives.
Collaborations
Throughout his career, Brautigam has collaborated with distinguished colleagues such as Gunter Neef and Gerald Kirsch. Their collective efforts have amplified the research output and have been instrumental in bringing innovative solutions to the market.
Conclusion
Matthias Brautigam is a notable figure in the landscape of pharmaceutical inventions. His research into vitamin D derivatives illustrates not only his ingenuity but also his dedication to improving health outcomes through scientific discovery. With further collaboration and exploration, Brautigam's work holds promise for future innovations in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile